Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful?

Authors

Institutions

Publication Details

Journal
Polskie Archiwum Medycyny Wewnętrznej
Published
2025-04-07
DOI
https://doi.org/10.20452/pamw.16987
Citations
4
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
6.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful?

Martyna Kuleta, Michael K. Gibson, Iwona Kowalska‐Bobko, Zbigniew Siudak et al.
4 citations
Polskie Archiwum Medycyny Wewnętrznej
Retinal Diseases and Treatments
6.83
article

Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful?

Martyna Kuleta, Michael K. Gibson, Iwona Kowalska‐Bobko, Zbigniew Siudak, Łukasz Szarpak, Krzysztof Piotr Malinowski, Maria Cecilia Bahit
article en
4 citations

Abstract

No abstract available for this paper.
Polskie Archiwum Medycyny WewnętrznejVol. 135(4)
John Paul II Catholic University of Lublin (PL), Jagiellonian University (PL), Beth Israel Deaconess Medical Center (US), Harvard University (US), Jan Kochanowski University (PL), Baylor College of Medicine (US), Baim Institute for Clinical Research (US), Instituto de Neurología Cognitiva (AR), Imaging Center (US)
Openalex Percentile: Top 3%
Retinal Diseases and Treatments
6.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.